Table 1.
Study group Tornadon= 90 | Control group care as usualn= 90 | |||||
---|---|---|---|---|---|---|
Timepoints | Child (if ≥ 10 years) | Parents/caregivers | Professional (psychiatrist (T2) and general practitioner (T4 and T7)) | Child (if ≥ 10 years) | Parents/caregivers | Professional (psychiatrist or pediatrician) |
T1 = referral | HoNOSCA | ADHD-RS | HoNOSCA | ADHD-RS | ||
Kidscreen | HoNOSCA | Kidscreen | HoNOSCA | |||
EQ-5D | Kidscreen | EQ-5D | Kidscreen | |||
EQ-5D | EQ-5D | |||||
Extra questionsa | Extra questionsa | |||||
T2 = intake and start diagnostic process | HoNOSCA | ADHD-RS | ADHD-RS | HoNOSCA | ADHD-RS | ADHD-RS |
Kidscreen | HoNOSCA | CGI | Kidscreen | HoNOSCA | HoNOSCA | |
Kidscreen | HoNOSCA | Kidscreen | CGI | |||
EQ-5D | EQ-5D | |||||
T3 = consultation and end of diagnostic process | GGZ-thermometer | GGZ-thermometer | GGZ-thermometer | GGZ-thermometer | ||
T4 = start pharmacotherapy | HoNOSCA | ADHD-RS | ADHD-RS | HoNOSCA | ADHD-RS | ADHD-RS |
Kidscreen | HoNOSCA | CGI | Kidscreen | HoNOSCA | HoNOSCA | |
Kidscreen | Kidscreen | CGI | ||||
Tic-P | Tic-P | |||||
EQ-5D | EQ-5D | |||||
T5 = 6 weeks after start pharmacotherapy | HoNOSCA | ADHD-RS | HoNOSCA | ADHD-RS | ||
Kidscreen | HoNOSCA | Kidscreen | HoNOSCA | |||
Morisky | Kidscreen | Morisky | Kidscreen | |||
Morisky | Morisky | |||||
EQ-5D | EQ-5D | |||||
T6 = 9 months after T1 | Morisky | Morisky | Morisky | Morisky | ||
HoNOSCA | HoNOSCA | HoNOSCA | HoNOSCA | |||
Kidscreen | Kidscreen | Kidscreen | Kidscreen | |||
EQ-5D | EQ-5D | EQ-5D | EQ-5D | |||
T7 = 1 year after T0 | HoNOSCA | ADHD-RS | ADHD-RS | HoNOSCA | ADHD-RS | ADHD-RS |
Kidscreen | HoNOSCA | HoNOSCA | Kidscreen | HoNOSCA | HoNOSCA | |
EQ-5D | Kidscreen | CGI | EQ-5D | Kidscreen | CGI | |
Morisky | Tic-P | Morisky | Tic-P | |||
GGZ-thermometer | EQ-5D | GGZ-thermometer | EQ-5D | |||
Morisky | Morisky | |||||
GGZ-Thermometer | GGZ-thermometer |
aSex, family constitution, education level parents.